Manufacturer record
Maneesh Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Maneesh Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DXM2534, Doxylamine Succinate & Pyridoxine Hydrochloride Tablets (exp Jun 2028). CDTL, Mumbai (CDSCO lab) found it not of standard quality: The sample received does not conform to Manufacturers specification with respect to the test for Thickness. Listed in the April 2026 alert.
Records by type
3 records linked to Maneesh Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Doxylamine Succinate & Pyridoxine Hydrochloride Tablets | Batch DXM2534Mfg Jul 2025 · Exp Jun 2028 | The sample received does not conform to Manufacturers specification with respect to the test for ThicknessOther | CDTL, MumbaiCDSCO lab | Apr 2026 |
| Doxylamine Succinate, Pyridoxine Hydrochloride and Folic Acid Tablets. (Doxinate Forte) | Batch DOFM2202Mfg Feb 2022 · Exp Jan 2025 | DisintegrationDisintegration | RDTL GuwahatiState lab | Nov 2023 |
| Rosuvastatin Tablets IP 10mg (ROZUDOC-10 TABLETS) | Batch RAE1901Mfg Mar 2019 · Exp Feb 2021 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.